FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942308489> ?p ?o ?g. }

• W2942308489 endingPage "886" @default.
• W2942308489 startingPage "877" @default.
• W2942308489 abstract "Diffuse-type tenosynovial giant-cell tumour is a rare, locally aggressive, and difficult-to-treat soft tissue tumour. Clinical and surgical outcomes depend on multiple factors, including preoperative diagnostic assessment, the localisation and extent of disease, and possibly the choice of treatment modalities by orthopaedic surgeons. We did a retrospective cohort study to characterise global surgical treatment protocols, and assess surgical outcomes, complications, and functional results in patients with diffuse-type tenosynovial giant-cell tumours.In this international, multicentre, retrospective cohort study, we included consecutive patients treated in 31 sarcoma reference centres between Jan 1, 1990, and Dec 31, 2017. Eligible patients were of any age and had histologically proven diffuse-type tenosynovial giant-cell tumour of large joints. Patient data were retrieved from the local databases of participating centres. Patients with localised-type tenosynovial giant-cell tumour were excluded. In the analysis, we only included patients with complete core criteria data regarding admission status, date of treatment, type of treatment at participating centre, and first local recurrence after treatment. We used a non-parametric method to estimate recurrence-free survival at 3, 5, and 10 years after initial surgical resection in a tertiary centre. We used a multivariate Cox regression model to estimate the effect of risk factors. We also present subgroup analyses of disease status at presentation (primary vs recurrent disease) and recurrence-free survival by surgery type (open surgery vs arthroscopic synovectomy), and prespecified risk factors were tested in a univariate and multivariable analyses, with an endpoint of first local recurrence after treatment in a tertiary centre.Data collection for these analyses occurred between January, 2016, and May, 2018. We received the records of 1192 patients, of which 966 (81%) were surgically treated and had complete information on core criteria. 445 patients were admitted with therapy-naive disease of the knee and were primarily treated in a tertiary centre. Since patients with wait and see treatment do not have a starting date of treatment, these patients were excluded in the calculation of median follow-up time for all patients. For this calculation we used time of surgery as a starting date. 758 (64%) of 1192 patients had knee involvement and 628 (54%) of 1163 patients with complete data on type of surgery had one-staged open synovectomy. At a median follow-up of 54 months (IQR 27-97), recurrent disease developed in 425 (44%) of all 966 surgically treated cases, and recurrence-free survival was 62% (95% CI 59-65) at 3 years, 55% (51-58) at 5 years, and 40% (35-45) at 10 years. Surgical complications were reported in 105 (12%) of 906 patients who had complete data on surgical complications. Pain improved after surgical treatment in 255 (59%) of 434 patients and swelling improved in 328 (72%) of 453 patients who had complete data.This study of patients with diffuse-type tenosynovial giant-cell tumour provides a comprehensive and up-to-date disease overview, assessing the clinical profile and management of the disease in multiple specialised referral centres. Surgical treatment of diffuse-type tenosynovial giant cell tumours is not a definitive treatment for every patient because it involves a high risk for local recurrent disease and a relatively high risk for postoperative complications. After surgical treatment in treatment-naive patients, risk factors for recurrent disease in individual patients were not identified in what we believe is the largest cohort to date.Daiichi Sankyo." @default.
• W2942308489 created "2019-05-03" @default.
• W2942308489 creator A5002302013 @default.
• W2942308489 creator A5004811626 @default.
• W2942308489 creator A5010888827 @default.
• W2942308489 creator A5020344461 @default.
• W2942308489 creator A5025880308 @default.
• W2942308489 creator A5025935523 @default.
• W2942308489 creator A5032421870 @default.
• W2942308489 creator A5048423025 @default.
• W2942308489 creator A5059407571 @default.
• W2942308489 creator A5059690678 @default.
• W2942308489 creator A5060954086 @default.
• W2942308489 creator A5061040954 @default.
• W2942308489 creator A5080548972 @default.
• W2942308489 creator A5082940920 @default.
• W2942308489 creator A5088078553 @default.
• W2942308489 creator A5091002194 @default.
• W2942308489 creator A5091065607 @default.
• W2942308489 date "2019-06-01" @default.
• W2942308489 modified "2023-10-11" @default.
• W2942308489 title "Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study" @default.
• W2942308489 cites W1822348759 @default.
• W2942308489 cites W1896692351 @default.
• W2942308489 cites W1929661134 @default.
• W2942308489 cites W2019694294 @default.
• W2942308489 cites W2021295549 @default.
• W2942308489 cites W2024527432 @default.
• W2942308489 cites W2032433154 @default.
• W2942308489 cites W2048491570 @default.
• W2942308489 cites W2053237929 @default.
• W2942308489 cites W2055747247 @default.
• W2942308489 cites W2060634867 @default.
• W2942308489 cites W2103079055 @default.
• W2942308489 cites W2105457206 @default.
• W2942308489 cites W2120017555 @default.
• W2942308489 cites W2120959053 @default.
• W2942308489 cites W2241678466 @default.
• W2942308489 cites W2266702665 @default.
• W2942308489 cites W2325862423 @default.
• W2942308489 cites W2498609810 @default.
• W2942308489 cites W2606318060 @default.
• W2942308489 cites W2606464606 @default.
• W2942308489 cites W2742775875 @default.
• W2942308489 cites W2755225231 @default.
• W2942308489 cites W2767648131 @default.
• W2942308489 cites W2789626795 @default.
• W2942308489 cites W2810492845 @default.
• W2942308489 cites W2811254154 @default.
• W2942308489 cites W4211101039 @default.
• W2942308489 doi "https://doi.org/10.1016/s1470-2045(19)30100-7" @default.
• W2942308489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31029509" @default.
• W2942308489 hasPublicationYear "2019" @default.
• W2942308489 type Work @default.
• W2942308489 sameAs 2942308489 @default.
• W2942308489 citedByCount "62" @default.
• W2942308489 countsByYear W29423084892019 @default.
• W2942308489 countsByYear W29423084892020 @default.
• W2942308489 countsByYear W29423084892021 @default.
• W2942308489 countsByYear W29423084892022 @default.
• W2942308489 countsByYear W29423084892023 @default.
• W2942308489 crossrefType "journal-article" @default.
• W2942308489 hasAuthorship W2942308489A5002302013 @default.
• W2942308489 hasAuthorship W2942308489A5004811626 @default.
• W2942308489 hasAuthorship W2942308489A5010888827 @default.
• W2942308489 hasAuthorship W2942308489A5020344461 @default.
• W2942308489 hasAuthorship W2942308489A5025880308 @default.
• W2942308489 hasAuthorship W2942308489A5025935523 @default.
• W2942308489 hasAuthorship W2942308489A5032421870 @default.
• W2942308489 hasAuthorship W2942308489A5048423025 @default.
• W2942308489 hasAuthorship W2942308489A5059407571 @default.
• W2942308489 hasAuthorship W2942308489A5059690678 @default.
• W2942308489 hasAuthorship W2942308489A5060954086 @default.
• W2942308489 hasAuthorship W2942308489A5061040954 @default.
• W2942308489 hasAuthorship W2942308489A5080548972 @default.
• W2942308489 hasAuthorship W2942308489A5082940920 @default.
• W2942308489 hasAuthorship W2942308489A5088078553 @default.
• W2942308489 hasAuthorship W2942308489A5091002194 @default.
• W2942308489 hasAuthorship W2942308489A5091065607 @default.
• W2942308489 hasBestOaLocation W29423084892 @default.
• W2942308489 hasConcept C126322002 @default.
• W2942308489 hasConcept C141071460 @default.
• W2942308489 hasConcept C142724271 @default.
• W2942308489 hasConcept C144301174 @default.
• W2942308489 hasConcept C167135981 @default.
• W2942308489 hasConcept C2778256501 @default.
• W2942308489 hasConcept C2908810772 @default.
• W2942308489 hasConcept C38180746 @default.
• W2942308489 hasConcept C50382708 @default.
• W2942308489 hasConcept C71924100 @default.
• W2942308489 hasConcept C72563966 @default.
• W2942308489 hasConcept C77076574 @default.
• W2942308489 hasConceptScore W2942308489C126322002 @default.
• W2942308489 hasConceptScore W2942308489C141071460 @default.
• W2942308489 hasConceptScore W2942308489C142724271 @default.
• W2942308489 hasConceptScore W2942308489C144301174 @default.
• W2942308489 hasConceptScore W2942308489C167135981 @default.
• W2942308489 hasConceptScore W2942308489C2778256501 @default.

• next